0

538837

JSTL

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Jeevan Scientific Technology L Share Price Today

Investment Returns

Over 1 Month -2.11% Over 3 Months 27.00% Over 6 Months 29.67% Over 1 Year 108.79%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Jeevan Scientific Technology L fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 158.40
  • P/E Ratio (TTM) 96.40
  • Beta 0.69
  • Book Value / share 36.79
  • Return on equity 1.48%
  • EPS (TTM) 0.83
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 1.59
info icon alternate text

Jeevan Scientific Technology L Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 18.38
Operating Expense 16.51
Net Profit 1.59
Net Profit Margin (%) 8.65
Earnings Per Share (EPS) 0.80
EBITDA 3.84
Effective Tax Rate (%) 28.25
Particulars DEC 2025 (Values in Cr)
Revenue 16.91
Operating Expense 13.99
Net Profit 2.30
Net Profit Margin (%) 13.60
Earnings Per Share (EPS) 1.45
EBITDA 4.83
Effective Tax Rate (%) 25.80
Particulars SEP 2025 (Values in Cr)
Revenue 10.43
Operating Expense 10.79
Net Profit -0.09
Net Profit Margin (%) -0.86
Earnings Per Share (EPS) -0.05
EBITDA 1.74
Effective Tax Rate (%) 11.11
Particulars JUN 2025 (Values in Cr)
Revenue 8.22
Operating Expense 11.18
Net Profit -2.16
Net Profit Margin (%) -26.27
Earnings Per Share (EPS) -1.36
EBITDA -0.73
Effective Tax Rate (%) 16.60
Particulars MAR 2025 (Values in Cr)
Revenue 8.92
Operating Expense 11.70
Net Profit -1.34
Net Profit Margin (%) -15.02
Earnings Per Share (EPS) -0.86
EBITDA -0.76
Effective Tax Rate (%) 49.43
Particulars MAR 2026 (Values in Cr)
Revenue 53.93
Operating Expense 52.48
Net Profit 1.65
Net Profit Margin (%) 3.05
Earnings Per Share (EPS) 0.83
EBITDA 9.67
Effective Tax Rate (%) 37.50
Particulars MAR 2025 (Values in Cr)
Revenue 43.61
Operating Expense 43.47
Net Profit 0.74
Net Profit Margin (%) 1.69
Earnings Per Share (EPS) 0.47
EBITDA 7.10
Effective Tax Rate (%) 3.89
Particulars MAR 2024 (Values in Cr)
Revenue 38.50
Operating Expense 40.41
Net Profit -1.05
Net Profit Margin (%) -2.72
Earnings Per Share (EPS) -0.68
EBITDA 5.05
Effective Tax Rate (%) 14.63
Particulars MAR 2023 (Values in Cr)
Revenue 36.18
Operating Expense 40.86
Net Profit -3.00
Net Profit Margin (%) -8.29
Earnings Per Share (EPS) -1.96
EBITDA 2.34
Effective Tax Rate (%) 17.12
Particulars MAR 2022 (Values in Cr)
Revenue 56.55
Operating Expense 44.12
Net Profit 12.26
Net Profit Margin (%) 21.67
Earnings Per Share (EPS) 8.15
EBITDA 22.99
Effective Tax Rate (%) 33.18
Particulars MAR 2025 (Values in Cr)
Book Value / Share 31.54
ROE % 0.14
ROCE % 2.79
Total Debt to Total Equity 0.35
EBITDA Margin 17.32
Particulars MAR 2024 (Values in Cr)
Book Value / Share 31.28
ROE % -2.75
ROCE % -1.04
Total Debt to Total Equity 0.24
EBITDA Margin 13.39
Particulars MAR 2023 (Values in Cr)
Book Value / Share 31.13
ROE % -6.20
ROCE % -4.33
Total Debt to Total Equity 0.23
EBITDA Margin 6.72
Particulars MAR 2022 (Values in Cr)
Book Value / Share 33.06
ROE % 21.66
ROCE % 27.40
Total Debt to Total Equity 0.27
EBITDA Margin 27.51
Particulars MAR 2021 (Values in Cr)
Book Value / Share 22.89
ROE % 40.32
ROCE % 36.52
Total Debt to Total Equity 0.49
EBITDA Margin 42.34
Particulars MAR 2025 (Values in Cr)
Book Value / Share 32.16
ROE % 1.48
ROCE % 3.13
Total Debt to Total Equity 0.19
EBITDA Margin 16.42
Particulars MAR 2024 (Values in Cr)
Book Value / Share 31.53
ROE % -2.16
ROCE % -0.85
Total Debt to Total Equity 0.15
EBITDA Margin 13.17
Particulars MAR 2023 (Values in Cr)
Book Value / Share 31.21
ROE % -6.07
ROCE % -4.32
Total Debt to Total Equity 0.22
EBITDA Margin 6.66
Particulars MAR 2022 (Values in Cr)
Book Value / Share 33.06
ROE % 22.02
ROCE % 27.70
Total Debt to Total Equity 0.26
EBITDA Margin 33.53
Particulars MAR 2021 (Values in Cr)
Book Value / Share 23.69
ROE % 36.81
ROCE % 33.44
Total Debt to Total Equity 0.46
EBITDA Margin 46.97
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.24
Total Assets 78.29
Total Liabilities 78.29
Total Equity 50.07
Share Outstanding 1
Price to Book Ratio 1.25
Return on Assets (%) 0.17
Return on Capital (%) 0.21
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.54
Total Assets 67.86
Total Liabilities 67.86
Total Equity 48.63
Share Outstanding 1
Price to Book Ratio 1.63
Return on Assets (%) -1.91
Return on Capital (%) -2.18
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 6.83
Total Assets 65.92
Total Liabilities 65.92
Total Equity 48.42
Share Outstanding 1
Price to Book Ratio 1.56
Return on Assets (%) -4.62
Return on Capital (%) -5.56
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 29.71
Total Assets 77.87
Total Liabilities 77.87
Total Equity 50.58
Share Outstanding 1
Price to Book Ratio 3.93
Return on Assets (%) 15.33
Return on Capital (%) 18.92
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 6.21
Total Assets 65.97
Total Liabilities 65.97
Total Equity 35.02
Share Outstanding 1
Price to Book Ratio 2.59
Return on Assets (%) 17.79
Return on Capital (%) 25.88
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.20
Total Assets 70.61
Total Liabilities 70.61
Total Equity 50.91
Share Outstanding 1
Price to Book Ratio 1.25
Return on Assets (%) 1.04
Return on Capital (%) 1.24
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.51
Total Assets 59.91
Total Liabilities 59.91
Total Equity 48.80
Share Outstanding 1
Price to Book Ratio 1.63
Return on Assets (%) -1.75
Return on Capital (%) -1.98
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 6.12
Total Assets 63.75
Total Liabilities 63.75
Total Equity 48.31
Share Outstanding 1
Price to Book Ratio 1.56
Return on Assets (%) -4.71
Return on Capital (%) -5.51
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 29.71
Total Assets 77.87
Total Liabilities 77.87
Total Equity 50.58
Share Outstanding 1
Price to Book Ratio 3.93
Return on Assets (%) 15.74
Return on Capital (%) 19.43
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 5.68
Total Assets 63.77
Total Liabilities 63.77
Total Equity 36.24
Share Outstanding 1
Price to Book Ratio 2.59
Return on Assets (%) 17.65
Return on Capital (%) 24.16
Particulars MAR 2025 (Values in Cr)
Net Income 0.05
Cash from Operations 10.07
Cash from Investing -15.61
Cash from Financing 5.24
Net change in Cash -0.30
Free Cash Flow 26.10
Particulars MAR 2024 (Values in Cr)
Net Income -1.60
Cash from Operations 4.66
Cash from Investing -11.52
Cash from Financing 2.34
Net change in Cash -6.28
Free Cash Flow 16.69
Particulars MAR 2023 (Values in Cr)
Net Income -3.68
Cash from Operations -3.65
Cash from Investing -6.93
Cash from Financing -9.54
Net change in Cash -22.87
Free Cash Flow 4.51
Particulars MAR 2022 (Values in Cr)
Net Income 18.34
Cash from Operations 25.64
Cash from Investing -1.20
Cash from Financing 5.67
Net change in Cash 24.02
Free Cash Flow 27.98
Particulars MAR 2021 (Values in Cr)
Net Income 13.64
Cash from Operations 8.95
Cash from Investing -0.79
Cash from Financing -0.13
Net change in Cash 4.01
Free Cash Flow 9.74
Particulars MAR 2025 (Values in Cr)
Net Income 0.77
Cash from Operations 2.83
Cash from Investing -9.84
Cash from Financing 6.57
Net change in Cash -0.30
Free Cash Flow 13.14
Particulars MAR 2024 (Values in Cr)
Net Income -1.22
Cash from Operations 4.50
Cash from Investing -4.69
Cash from Financing -3.65
Net change in Cash -5.61
Free Cash Flow 9.72
Particulars MAR 2023 (Values in Cr)
Net Income -3.61
Cash from Operations -3.53
Cash from Investing -7.26
Cash from Financing -10.02
Net change in Cash -23.59
Free Cash Flow 2.72
Particulars MAR 2022 (Values in Cr)
Net Income 18.34
Cash from Operations 25.64
Cash from Investing -1.20
Cash from Financing 5.67
Net change in Cash 24.02
Free Cash Flow 27.98
Particulars MAR 2021 (Values in Cr)
Net Income 13.17
Cash from Operations 8.37
Cash from Investing -0.79
Cash from Financing -0.13
Net change in Cash 3.80
Free Cash Flow 9.17
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 8412.30 61.83 12.76 120955.97 6680.00 8624.20
FORTIS MALAR HOSPITALS LIMITED 52.27 23.65 2.85 97.96 40.75 76.00
SHREE PACETRONIX LTD. 140.00 16.71 2.94 52.50 66.10 283.15
TRANSGENE BIOTEK LTD. 3.01 0.00 2.72 22.81 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 8412.30 80.57 12.14 120955.97 6680.00 8624.20
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 38.72 0.00 -9.42 28.92 30.30 57.48
KOVAI MEDICAL CENTER & HO 5841.00 26.14 4.84 6390.05 5010.00 6725.00

Jeevan Scientific Technology L shareholding pattern

Holding
69.75%
30.24%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Jeevan Scientific Technology L Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
79.50 -0.63 redarrow
red-green-graph indicator
7 Bearish
9 Bullish
  • 5 Days 79.50
  • 26 Days 79.70
  • 10 Days 79.40
  • 50 Days 78.20
  • 12 Days 79.40
  • 100 Days 73.70
  • 20 Days 79.70
  • 200 Days 66.60
80.34 PIVOT
First Support 78.68 First Resistance 81.66 Second Support 77.36 Second Resistance 83.32 Third Support 75.70 Third Resistance 84.64
RSI 50.94 ADX 5.35 MACD -0.30 Williams % R -37.45 Commodity Channel Index (CCI) 9.59
Date 2026-06-18 Week 18077.00 Same Day 3998.00 Month 18564.00
1 Year 0.70 3 Year 0.64
Over 1 Month
-2.11% down
Over 1 Year
108.79% down
Over 3 Months
27.00% down
Over 3 Years
20.25% down
Over 6 Months
29.67% down
Over 5 Years
-4.06% down

Jeevan Scientific Technology L Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
21 Sep 2022 1.2 Final 23 Sep 2022 Equity shares
07 Sep 2021 0.5 Final 08 Sep 2021 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Jeevan Scientific Technology Ltd?

Answer Field

Jeevan Scientific Technology Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 79.50 as on Jun 19 2026 03:29 PM.

What is the Market Cap of Jeevan Scientific Technology Ltd Share?

Answer Field

The market cap of Jeevan Scientific Technology Ltd for NSE ₹ 0.00 & for BSE ₹ 158.40 as on Jun 19 2026 03:29 PM.

What is the 52 Week High and Low of Jeevan Scientific Technology Ltd?

Answer Field

The 52 Week High and Low of Jeevan Scientific Technology Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 93.90 and ₹ 32.85.

What is 1 year return for Jeevan Scientific Technology Ltd?

Answer Field

The 1 year returns on the stock has been 108.79%.

What is the P/E Ratio of Jeevan Scientific Technology Ltd Share?

Answer Field

As on Jun 19 2026 03:29 PM the price-to-earnings (PE) ratio for Jeevan Scientific Technology Ltd share is 96.40.

What is the PB ratio of Jeevan Scientific Technology Ltd Share?

Answer Field

As on Jun 19 2026 03:29 PM, the price-to-book (PB) ratio for Jeevan Scientific Technology Ltd share is 36.79.

How to Buy Jeevan Scientific Technology Ltd Share?

Answer Field

You can trade in Jeevan Scientific Technology Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Jeevan Scientific Technology Ltd Share on Bajaj Broking App?

Answer Field

To buy Jeevan Scientific Technology Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Jeevan Scientific Technology Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|